Role of early life immune regulation in asthma development

Johanna Krusche1,2, Sarah Basse1, Bianca Schaub3,4

  • 1University Children's Hospital Munich, LMU Munich, Lindwurmstr.4, 80337, Munich, Germany.

Seminars in Immunopathology
|December 25, 2019
PubMed

Insights

Childhood asthma development involves genetic, epigenetic, and environmental factors influencing immune system maturation. Understanding these interactions is key for developing effective prevention and treatment strategies for healthy immune development.

Area of Science:

  • Immunology
  • Developmental Biology
  • Environmental Health

Background:

  • Childhood asthma development is a complex interplay of genetic, epigenetic, and environmental factors.
  • The developing immune system in pregnancy and early childhood is highly susceptible to external influences.
  • Both immutable (genetics) and modifiable (epigenetics) factors shape immune responses.

Purpose of the Study:

  • To review the effects of exogenous and endogenous factors on a child's maturing immune system.
  • To delineate the importance of immune system regulation for preventing and treating childhood asthma.
  • To explore potential intervention strategies for early-life immune modulation.

Main Methods:

  • This review synthesizes existing research on immune system development in early life.
  • It examines the impact of prenatal and postnatal factors on immune maturation.
  • The review discusses the roles of innate immunity (e.g., innate lymphoid cells) and adaptive immunity (e.g., T-cell subpopulations).

Main Results:

  • Prenatal factors (maternal nutrition, smoking, infections) and postnatal factors (mode of delivery) significantly influence immune regulation.
  • Balanced innate immunity and T-cell equilibrium are crucial for healthy immune maturation and preventing inflammation.
  • Later childhood may require compensatory mechanisms to correct deviant immune trajectories.

Conclusions:

  • Early life interventions targeting immune system maturation can potentially prevent or treat childhood asthma.
  • Understanding the complex interactions between genetics, epigenetics, and environment is vital for developing targeted strategies.
  • Modulating epigenetic regulations offers a promising avenue for early prevention and treatment of immune-related disorders.

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.1K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
713
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
1.7K